As evidenced from animal studies where mutant SOD1 was removed specifically from astrocytes in the SOD1G37R ALS mouse (using a GFAP-Cre mouse), astrocytes appear to drive late disease progression. Here, GFAP is linked to amyotrophic lateral sclerosis.